News
Seattle biotech firm, Dendreon on verge of a groundbreaking cancer vaccine
April 25, 2010/
A prostate-cancer treatment, if approved this week, could launch a whole new way to battle tumors — by firing up the body’s natural defenses.
By Sandi Doughton
Seattle Times science reporter
Full Story: http://seattletimes.nwsource.com/html/localnews/2011695773_dendreon25m.html



